Snam S.p.A./ IT0003153415 /
14/06/2024 16:17:07 | Var. +0.0620 | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
4.7120USD | +1.33% | 330 Fatturato: 1,333.4960 |
-Quantità in denaro: - | -Quantità in lettera: - | 15.35 bill.USD | - | - |
GlobeNewswire
01:16
ROSEN, LEADING INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
15/06
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Humana Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
15/06
ROSEN, A LEADING LAW FIRM, Encourages FAT Brands Inc. Investors to Secure Counsel Before Important D...
GlobeNewswire
15/06
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Intel Corporation Investors to Secure Counsel Befor...
GlobeNewswire
15/06
ROSEN, A LEADING NATIONAL FIRM, Encourages Harbor Diversified, Inc. Investors to Secure Counsel Befo...
Newsfile Corp
15/06
ROSEN, A TOP RANKED LAW FIRM, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important...
Newsfile Corp
15/06
TOP RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Secure Counsel Before Important De...
Newsfile Corp
15/06
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Bef...
GlobeNewswire
15/06
GDRX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure...